Objectives: To study the compliance to risk factor modifications and factors related to it, which may be different between early-onset (15–45 years) and late-onset (>45 years) stroke patients. These issues have not yet been addressed properly. Methods: We selected 170 early-onset and 340 late-onset stroke patients from the Asan Stroke Registry. The patients were then followed for 1–5 years (an average of 3.4 years) after the onset of stroke. We used a standardized questionnaire to assess the levelof compliance and examine the factors contributing to noncompliance. Results: Ninety-six early-onset and 160 late-onset patients completed a standardized questionnaire. Early-onset patients were less compliant than late-onset patients in the use of antihypertensive medication (p < 0.01), the cessation of cigarette smoking (p < 0.05) and in regular exercise (p < 0.05). Multivariate analysis showed that factors related to noncompliance in early-onset stroke patients included ‘a lack of insurance’ (noncompliance with the use of antihypertensive medication) and male gender (noncompliance with participation in regular exercise). Factors related to noncompliance in late-onset stroke patients included a high number of cigarettes consumed before the stroke (noncompliance with the cessation of smoking), the lack of regular exercise and a severe modified Rankin scale (noncompliance with regular exercise). Conclusion: Early-onset stroke patients are generally less compliant than late-onset stroke patients and the factors related to noncompliance in these groups are different. Therefore, strategies should be developed for improving patient compliance, based on these differences.

Keywords:
Cerebrovascular disease, early onset, Stroke risk factors
1.
Hier DB, Foulkes MA, Swiontoniowski M, et al: Stroke recurrence within 2 years after ischemic infarction. Stroke 1991;22:155–161.
2.
Lai SM, Alter M, Friday G, et al: A multifactorial analysis of risk factors for recurrence of ischemic stroke. Stroke 1994;25:958–962.
3.
Burn J, Dennis M, Bamford J, et al: Long-term risk of recurrent stroke after a first-ever stroke: the Oxfordshire community stroke project. Stroke 1994;25:333–337.
4.
Love BB, Biller J, Jones MP, et al: Cigarette smoking; a risk factor for cerebral infarction in young adults. Arch Neurol 1990;47:693–698.
5.
Gill JS, Shipley MJ, Tsementzis SA, et al: Alcohol consumption – A risk factor for hemorrhagic and non-hemorrhagic stroke. Am J Med 1991;90:489–497.
6.
Kiely DK, Wolf PA, Cupples LA, et al: Physical activity and stroke risks: the Framingham study. Am J Epidemiol 1994;140:608–620.
7.
Choi-Kwon S, Kim JS: Lifestyle factors and risk of stroke in Seoul, South Korea. J Stroke Cerebrovasc Dis 1998;7:414–420.
8.
Suter PM, Vetter W: Brief critical reviews: alcohol and ischemic stroke. Nutr Rev 1999;57:310–326.
9.
Gorelick PB: Stroke prevention. Arch Neurol 1995;52:347–355.
10.
Wolfe C, Stojcevic N, Stewart J: The effectiveness of measures aimed at reducing the incidence of stroke; in Wolfe C, Rudd T, Beech R (eds): Stroke Services and Research. London, The Stroke Association, 1996, pp 39–86.
11.
Redfern J, McKevitt C, Dundas R, et al: Behavioral risk factor prevalence and lifestyle change after stroke: a prospective study. Stroke 2000;31:1877–1881.
12.
Clark LT: Improving compliance and increasing control of hypertension: needs of special hypertensive populations. Am Heart J 1991;121:664–669.
13.
Sharkness CM, Snow DA: The patient’s view of hypertension and compliance. Am J Prev Med 1992;8:141–146.
14.
Landers R, Riccobene A, Beyreuther M, et al: Predictors of long-term compliance in attending a worksite hypertension programme. J Hum Hypert 1993;7:577–579.
15.
Rudd P: Clinicians and patients with hypertension: unsettled issues about compliance. Am Heart J 1995;130:572–579.
16.
Bittar N: Maintaining long-term control of blood pressure: the role of improved compliance. Clin Cardiol 1995;18(suppl 3):12–16.
17.
Sorlie PD, Kannel WB: A description of cigarette smoking cessation and resumption in the Framingham study. Prev Med 1990;19:335–345.
18.
Fiore MC, Novotny TE, Pierce JP, et al: Methods used to quit smoking in the United States. Do cessation programs help? JAMA 1990;263:2760–2765.
19.
Salive ME, Cornoni-Huntley J, LaCroix AZ, et al: Predictors of smoking cessation and relapse in older adults. Am J Pubic Health 1992;82:1268–1271.
20.
Joseph LN, Babikian VL, Allen NC, et al: Risk factor modification in stroke prevention: the experience of a stroke clinic. Stroke 1999;30:16–20.
21.
Hillen T, Dundas R, Lawrence E, et al: Antithrombotic and antihypertensive management 3 months after ischemic stroke: a prospective study in an inner city population. Stroke 2000;31:469–475.
22.
Sappok T, Faulstich A, Stuckert E, et al: Compliance with secondary prevention of ischemic stroke: a prospective evaluation. Stroke 2001;32:1884–1889.
23.
Kwon SU, Kim JS, Lee MC: Ischemic stroke in Korean young adults. Acta Neurol Scand 2000;101:19–24.
24.
Hindfelt B, Nilsson O: Long-term prognosis of ischemic stroke in young adults. Acta Neurol Scand 1992;86:440–445.
25.
Neau JP, Ingrand P, Mouille-Brachet C, et al: Functional recovery and social outcome after cerebral infarction in young adults. Cerebrovasc Dis 1998;8:296–302.
26.
Kim JS, Yoon SS: Perspectives of stroke in persons living in Seoul, South Korea: a survey of 1,000 subjects. Stroke 1997;28:1165–1169.
27.
Hansagi H, Romelsjo A, Gerhardsson de Verdier M, et al: Alcohol consumption and stroke mortality: 20-year follow-up of 15,077 men and women. Stroke 1995;26:1768–1773.
28.
Kim JS, Choi-Kwon S: Poststroke depression and emotional incontinence: correlation with lesion location. Neurology 2000;54:1805–1810.
29.
Folstein MF, Folstein SE, McHugh PR: ‘Mini-mental state’. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189–198.
30.
Schaub AF, Steiner A, Vetter W: Compliance to treatment. Clin Exp Hypertens 1993;15:1121–1130.
31.
Kjellgren KI, Ahlner J, Saljo R: Taking antihypertensive medication – Controlling or co-operating with patients? Int J Cardiol 1995;47:257–268.
32.
Friday GH: Antihypertensive medication compliance in African-American stroke patients: behavioral epidemiology and interventions. Neuroepidemiology 1999;18:223–230.
33.
Degoulet P, Menard J, Vu HA, et al: Factors predictive of attendance at clinic and blood pressure control in hypertensive patients. Br Med J 1983;287:88–93.
34.
Smith EO, Curb JD, Hardy RJ, et al: Clinic attendance in the hypertension detection and follow-up program. Hypertension 1982;4:710–715.
35.
Kim CS, Yon HH, Cho CY, et al: A study of compliance on antihypertensive treatment. Family Physician 1990;11:1–8.
© 2005 S. Karger AG, Basel
2006
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.